在认知障碍中解决神经炎症,使用单向和多向的胺H3受体调节器
Flávia Barrio Lopes1,2, João Paulo S Fernandes2, Elisa Uliassi3
1Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Current topics in medicinal chemistry
|August 26, 2024
概括
组胺H3受体 (H3R) 抗剂在治疗与神经炎症相关的认知障碍方面表现有前途. 准H3R为中枢神经系统疾病提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 神经炎症,包括质激活和细胞因子释放,在中枢神经系统 (CNS) 疾病中显著导致认知功能障碍.
- 已知炎症媒介体 - - 胺在中枢神经系统内的神经炎症过程中起着至关重要的作用.
- 组胺H3受体 (H3R) 独特地定位在中枢神经系统中,调节神经递质的释放,使其成为治疗点.
研究的目的:
- 为了审查基因组激素传播在神经炎症相关认知障碍中的作用.
- 要突出胺H3受体 (H3R) 在这些过程中的参与.
- 讨论H3R抗剂和逆激动剂的抗神经炎症潜力.
主要方法:
- 审查关于神经炎症,组织因子系统和H3R的现有文献.
- 对研究中枢神经系统疾病的H3R配体的研究分析.
- 专注于H3R在认知障碍和神经炎症疾病中的作用.
主要成果:
- 基因组激素通路,特别是涉及H3R,在潜在的认知障碍的神经炎症过程中至关重要.
- 在神经退行性疾病,ADHD和精神分裂症的临床前模型中,H3R抗剂/逆agonists已经证明了治疗潜力.
- 单标和多标的H3R配体都表现出抗神经炎症作用.
结论:
- 由H3R调节的基因组神经传递是以认知障碍为特征的中枢神经系统疾病的重要因素.
- H3R抗剂/逆agonists代表了一系列神经炎症和认知障碍的治疗有前途的治疗途径.
- 对H3R向疗法的进一步研究可能会导致对阿尔茨海默病,多动症和精神分裂症等疾病的新治疗方法.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
110
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
110
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
01:23Role of Neurotransmitters in Memory
488
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
488
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
410
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
410